‘Middlemen’ Markups Are Penalizing Patients, Says AAM
Cash Prices For Generic Drugs Are Substantially Higher Than Manufacturer Prices
Executive Summary
The Association for Accessible Medicines has launched its Markup Madness campaign, which seeks to draw attention to the disparity in cost between generic drugs upon entry to the supply chain and when purchased in pharmacies.
You may also be interested in...
US Patients Continue To Overpay For Off-Patent Drugs Despite $373bn In Savings
The US Association for Accessible Medicines’ annual report into generic and biosimilar savings has documented another year of increased cost savings thanks to off-patent drugs, but says some patients are still overpaying for their generic medicines.
US Patients Increasingly Reliant On Pharmacy Discount Cards For Generics
IQVIA has published a white paper examining the growing reliance on pharmacy discount cards to pay for prescriptions in the US.
Increased Transparency Key To Combating Drug Shortages, Says US Industry Alliance
The closure of a Teva manufacturing plant in California has raised concerns around access a number of medicines, something the End Drug Shortages Alliance says could be avoided through increased market transparency.